Business Context and Reporting Period
Company: American Vanguard Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: December 19, 2006
Event: Acquisition of assets by wholly-owned subsidiary, AMVAC Chemical Corporation.
Key Financial Metrics
This filing reports a strategic asset acquisition and does not contain audited financial statements, revenue figures, profit margins, cash flow data, debt levels, or liquidity metrics for the reporting period.
Material Changes
- Asset Acquisition: AMVAC acquired the Permethrin product line (a synthetic pyrethroid insecticide) from Syngenta Crop Protection, Inc.
- Scope: Acquisition includes crop and non-crop uses in the U.S., Mexico, and Canada.
- Assets Acquired: Registration rights, manufacturing/formulation know-how, inventories, customer lists, and trademarks (Ambush® and Prelude®).
- Market Context: The product line serves an estimated $40 million market covering fruit and vegetable crops and general pest control.
- Operational Impact: AMVAC now owns the complete Permethrin product line, having previously acquired the Ambush 25WP business in 2002.
Outlook and Management Commentary
- Immediate Action: Sales of Permethrin products will commence immediately.
- Product Relaunch: The liquid formulation of Ambush will be re-launched in the U.S. and Canada after a four-year absence from those markets.
- Distribution Strategy: Ambush will be distributed through national distributors in Mexico; Prelude sales will continue with existing distributors in the U.S. and Canada.
Investor Verification Checklist
- Verify the total purchase price and payment terms for the Permethrin asset acquisition (not disclosed in this filing).
- Confirm the impact of this acquisition on future revenue guidance and earnings per share.
- Assess the integration timeline for the re-launch of the Ambush liquid formulation.
- Review any regulatory conditions attached to the acquired registration rights in the U.S., Mexico, and Canada.